Skip to Content
COVID-19 Resources
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 03/26/20

Cheryl Pickett-Gies, MD, PhD


Cheryl Pickett-Gies, MD, PhD, joined the Investigational Drug Branch and CTEP in January of 2020 to focus on early clinical trials of immunotherapy agents. Before coming to IDB, she was a Clinical Research Medical Director in Oncology at Amgen.

Dr. Pickett earned her PhD in biochemistry at the University of California (UC) Davis and her MD at the University of Colorado. She completed internship and residency in Internal Medicine at UC Davis and a clinical and research fellowship in Endocrinology at the University of Colorado. She subsequently held academic appointments at the University of Colorado and then at the University of Washington Medical Centers before moving from academia to clinical development positions in the biotech/pharma sector, first at Merck and later at Amgen.

Dr. Pickett's early research focused on the mechanisms by which growth factors and hormones modulate activity of protein kinases and phosphatases; subsequently including work to elucidate how aberrancies in these signal transduction mechanisms modulate gene transcription and cell growth in tumor models. During her fellowship and academic appointments her clinical focus was on diagnosis and management of endocrine tumors; she was co-founder of a multidisciplinary endocrine tumor clinic at the University of Washington. Upon moving to biotech/pharma research in 2004, she has established broad oncology clinical trial expertise developing and conducting trials across phases1-3, covering a wide range of compounds, mechanisms of action, and tumor indications in both company sponsored and in collaborative projects.

About the Branch Chief

Jeffrey A. Moscow, MD Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in 2014 after serving part time since 2012, and was appointed Branch Chief in 2018. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. Dr. Moscow completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. More…